
Canadian Journal of Chemistry p. 501 - 508 (1982)
Update date:2022-07-30
Topics:
ApSimon, John W.
Yamasaki, Kazu
Fruchier, Alain
Chau, Alfred S.
Huber, Carol P.
The treatment of endrin (1) with sulfuric acid produces ketoendrin 2 from 6 to 8percent of another product that we show to be 2,3,4,4,5,6-hexachloro-12-oxapentacyclo<5.4.1.1.8,11.03,10.05,9>tridecane 3, based initially on spectral evidence and confirmed by a single crystal X-ray diffraction study.The formation of 3 involves an apparent and unusual carbon-carbon single bond cleavage in an epoxide accompanied by cycloaddition to a proximate carbon-carbon double bond.This transformation probably proceeds by the route outlined in ref. 1.Some of the observed nmr parameters of 3 are discussed in the light of its structure and a comparison is made with the observed spectra for endrin (1).
View MoreCHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Fujian Wanke Pharmaceutical Co., LTD.
Contact:+86-598-5026002
Address:Economic development zone,jiangle county
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:+86-15853188990
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Xinjiang Fufeng Biotechnologies Co., Ltd.
Contact:+86-539-7287111
Address:GANQUANPU INDUSTRIAL PARK, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA (TOUTUNHE DISTRICT) OF URUMQI
Doi:10.1016/j.poly.2019.01.044
(2019)Doi:10.1002/anie.202107982
(2021)Doi:10.1021/jo00411a020
(1978)Doi:10.1271/bbb.66.523
(2002)Doi:10.1021/ol036380l
(2004)Doi:10.1002/jhet.5570150214
(1978)